Also from this source

You just read:

Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV

News provided by

Inovio Pharmaceuticals, Inc.

Mar 07, 2011, 04:00 EST